Archit Organosys has notified the BSE of an upcoming Board of Directors meeting, scheduled for Saturday, May 16, 2026. The meeting has been convened to consider and approve the audited financial results of the company for the quarter and year ended March 31, 2026. Additionally, the board will consider the recommendation of a final dividend for the year ended March 31, 2026, subject to shareholder approval at the ensuing Annual General Meeting.

Board Meeting Details

The intimation, dated May 13, 2026, was submitted to the Listing Department of BSE Limited. The key details of the scheduled meeting are outlined below:

Trading Window Closure

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has closed the trading window for promoters, directors, senior managerial personnel, and their immediate relatives. The trading window closure is effective from April 1, 2026, and will remain in force until the expiry of 48 hours from the time the financial results for the aforesaid period become generally available to the public.

Archit organosys Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The certificate, dated April 13, 2026, covers the quarter ended March 31, 2026, and demonstrates the company's adherence to mandatory depositories compliance procedures.

Regulatory Compliance Details

The certificate was filed under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which mandates quarterly reporting by listed companies regarding their dematerialisation processes. The submission was made by Chairman & Whole time Director Kandarp K. Amin (DIN: 00038972) to BSE Limited at Phiroze Jeejeebhoy Towers, Mumbai.

Registrar Confirmation

MUFG Intime India Private Limited (formerly Link Intime India Private Limited), serving as the company's Registrar and Share Transfer Agent, issued the confirmation certificate on April 1, 2026. The registrar confirmed compliance with all dematerialisation requirements during the quarter ended March 31, 2026.

The registrar's certificate, signed by Sr. Vice President-Corporate Registry Ashok Shetty, confirms several key compliance aspects:

• Securities received from depository participants for dematerialisation were properly confirmed to depositories
• All security certificates were appropriately accepted or rejected within prescribed timelines
• Received certificates were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners
• Securities comprised in certificates have been listed on relevant stock exchanges

Company Information

Archit Organosys Limited operates from its registered office at 903, 9th Floor, Venus Benecia, Nr. Pakwan Restaurant, Bodakdev, S. G. Highway, Ahmedabad-380054, Gujarat. The company holds CIN: L24110GJ1993PLC019941 and maintains its operational facility at 25/9/A, Phase III, G.I.D.C., Naroada, Ahmedabad.

Regulatory Framework

The SEBI (Depositories and Participants) Regulations, 2018 require listed companies to file quarterly certificates confirming proper handling of dematerialisation processes. This regulatory framework ensures transparency in securities handling and maintains investor confidence in the depository system. The quarterly filing demonstrates the company's commitment to regulatory compliance and proper governance practices.